222 related articles for article (PubMed ID: 25339356)
1. Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor.
Stavrou EX; Fang C; Merkulova A; Alhalabi O; Grobe N; Antoniak S; Mackman N; Schmaier AH
Blood; 2015 Jan; 125(4):710-9. PubMed ID: 25339356
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation.
Fang C; Stavrou E; Schmaier AA; Grobe N; Morris M; Chen A; Nieman MT; Adams GN; LaRusch G; Zhou Y; Bilodeau ML; Mahdi F; Warnock M; Schmaier AH
Blood; 2013 Apr; 121(15):3023-32. PubMed ID: 23386129
[TBL] [Abstract][Full Text] [Related]
3. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
Fang C; Schmaier AH
Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner.
Barbieri SS; Amadio P; Gianellini S; Tarantino E; Zacchi E; Veglia F; Howe LR; Weksler BB; Mussoni L; Tremoli E
Circulation; 2012 Sep; 126(11):1373-84. PubMed ID: 22865892
[TBL] [Abstract][Full Text] [Related]
5. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
Breitenstein A; Stein S; Holy EW; Camici GG; Lohmann C; Akhmedov A; Spescha R; Elliott PJ; Westphal CH; Matter CM; Lüscher TF; Tanner FC
Cardiovasc Res; 2011 Feb; 89(2):464-72. PubMed ID: 20978007
[TBL] [Abstract][Full Text] [Related]
6. Physiologic activities of the contact activation system.
Schmaier AH
Thromb Res; 2014 May; 133 Suppl 1(0 1):S41-4. PubMed ID: 24759141
[TBL] [Abstract][Full Text] [Related]
7. Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin.
Shariat-Madar Z; Mahdi F; Warnock M; Homeister JW; Srikanth S; Krijanovski Y; Murphey LJ; Jaffa AA; Schmaier AH
Blood; 2006 Jul; 108(1):192-9. PubMed ID: 16514058
[TBL] [Abstract][Full Text] [Related]
8. A Novel Antithrombotic Mechanism Mediated by the Receptors of the Kallikrein/Kinin and Renin-Angiotensin Systems.
Schmaier AH
Front Med (Lausanne); 2016; 3():61. PubMed ID: 27965959
[TBL] [Abstract][Full Text] [Related]
9. The vascular side of plasma kallikrein.
Renné T
Blood; 2015 Jan; 125(4):589-90. PubMed ID: 25614637
[No Abstract] [Full Text] [Related]
10. Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas.
Peiró C; Vallejo S; Gembardt F; Palacios E; Novella S; Azcutia V; Rodríguez-Mañas L; Hermenegildo C; Sánchez-Ferrer CF; Walther T
J Physiol; 2013 May; 591(9):2275-85. PubMed ID: 23459756
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of angiotensin-converting enzyme 2 and Mas activation in inhibitory effects of angiotensin II Type 1 receptor blockade on vascular remodeling.
Iwai M; Nakaoka H; Senba I; Kanno H; Moritani T; Horiuchi M
Hypertension; 2012 Jul; 60(1):137-44. PubMed ID: 22665126
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor type-β inhibits Mas receptor expression in fibroblasts but not in myoblasts or differentiated myotubes; Relevance to fibrosis associated to muscular dystrophies.
Cofre C; Acuña MJ; Contreras O; Morales MG; Riquelme C; Cabello-Verrugio C; Brandan E
Biofactors; 2015; 41(2):111-20. PubMed ID: 25809912
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin -induced vasodilatation: Role of age, ACE1-inhibitory peptide, mas- and bradykinin receptors.
Siltari A; Korpela R; Vapaatalo H
Peptides; 2016 Nov; 85():46-55. PubMed ID: 27628189
[TBL] [Abstract][Full Text] [Related]
14. Mas Receptor Activation Contributes to the Improvement of Nitric Oxide Bioavailability and Vascular Remodeling During Chronic AT1R (Angiotensin Type-1 Receptor) Blockade in Experimental Hypertension.
Savoia C; Arrabito E; Parente R; Nicoletti C; Madaro L; Battistoni A; Filippini A; Steckelings UM; Touyz RM; Volpe M
Hypertension; 2020 Dec; 76(6):1753-1761. PubMed ID: 33070664
[TBL] [Abstract][Full Text] [Related]
15. Vascular smooth muscle-derived tissue factor is critical for arterial thrombosis after ferric chloride-induced injury.
Wang L; Miller C; Swarthout RF; Rao M; Mackman N; Taubman MB
Blood; 2009 Jan; 113(3):705-13. PubMed ID: 18931346
[TBL] [Abstract][Full Text] [Related]
16. Apold1 deficiency associates with increased arterial thrombosis in vivo.
Diaz-Cañestro C; Bonetti NR; Wüst P; Nageswaran V; Liberale L; Beer JH; Montecucco F; Lüscher TF; Bohacek J; Camici GG
Eur J Clin Invest; 2020 Feb; 50(2):e13191. PubMed ID: 31797367
[TBL] [Abstract][Full Text] [Related]
17. Counteraction between angiotensin II and angiotensin-(1-7) via activating angiotensin type I and Mas receptor on rat renal mesangial cells.
Xue H; Zhou L; Yuan P; Wang Z; Ni J; Yao T; Wang J; Huang Y; Yu C; Lu L
Regul Pept; 2012 Aug; 177(1-3):12-20. PubMed ID: 22561449
[TBL] [Abstract][Full Text] [Related]
18. Beneficial effects of the activation of the angiotensin-(1-7) MAS receptor in a murine model of adriamycin-induced nephropathy.
Silveira KD; Barroso LC; Vieira AT; Cisalpino D; Lima CX; Bader M; Arantes RM; Dos Santos RA; Simões-E-Silva AC; Teixeira MM
PLoS One; 2013; 8(6):e66082. PubMed ID: 23762470
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms at the F12 and KLKB1 loci have significant trait association with activation of the renin-angiotensin system.
Biswas N; Maihofer AX; Mir SA; Rao F; Zhang K; Khandrika S; Mahata M; Friese RS; Hightower CM; Mahata SK; Baker DG; Nievergelt CM; Vaingankar SM; O'Connor DT
BMC Med Genet; 2016 Mar; 17():21. PubMed ID: 26969407
[TBL] [Abstract][Full Text] [Related]
20. Participation of AT1 and Mas receptors in the modulation of inflammatory pain.
Costa AC; Romero TR; Pacheco DF; Perez AC; Savernini A; Santos RR; Duarte ID
Peptides; 2014 Nov; 61():17-22. PubMed ID: 25169953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]